PMX, founded in March 2020, a medical AI company, announced on Feb. 3 that it has signed a joint development research contract with the Center for MRI Research, Zuckerman Mind Brain Behavior Institute (ZMBBI) at Columbia University, USA to accelerate brain MR imaging and diagnosis.
ZMBBI brings together an extraordinary group of researchers from across Columbia University, in a state-of-the-art facility, to transform our understanding of the brain and mind. PMX, led by Dr. Kim Han Suk intends to create accessible solutions for dementia screening and management. Neuro solutions (BrainOMX) being commercialized by PMX will include technology that will be developed in partnership with ZMBBI under the guidance of PI, Dr. Sairam Geethanath.
PMX has created a brain MRI post-processing framework that can measure 3D volumes of brain structures, tissue composition (head fat), and resting-state functional connectivity (rs-fMRI). Early research based on data from Alzheimer Disease Neuroimaging Initiative (ADNI) and Konkuk University Hospital demonstrated the ability of BrainOMX to create image derived biomarkers to differentiate between control normal, mild cognitive impairment, and Alzheimer’s disease subjects. This work enabled the selection of PMX in TIPS (Tech Incubator Program for Startup Korea). BrainOMX solution envisions the integration of rapid brain MRI acquisition and reconstruction technique developed at Columbia University, fully automated structural and functional image processing, and intuitive reporting.
The two parties have embarked on a 2-year project for joint development and deployment of a dementia imaging solutions. Kim Han Suk, pointed out that the solution would be deployed for initial clinical validation in Korea. He expressed the excitement and enthusiasm of working with some of the world's best research centers and clinicians in Korea. He said “With this partnership we aim to accelerate the dementia diagnosis through A.I where the individuals can receive faster and more accurate objective data." and revealed the background of joint research and development.
